India has approved the use of Russia’s “Sputnik V” vaccine against Covid-19 based on strong immunogenicity data, the Economic Times newspaper reported on Monday.
It would be the third Covid-19 vaccine approved in India after AsztraZeneca’s Covishield, and local firm Bharat Biotech’s COVAXIN.
India is battling a massive second wave of Covid-19 infections, with more than 13.5 million cases. The country of 1.3 billion surpassed Brazil on Monday to become the world’s second worst affected country by Covid-19.
